Jiuzhitang Co., Ltd.
000989.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.54B
Close$
$13.78
59.5% upside
Current Fair Value
59.5% upsideUndervalued by 59.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.54 Billion |
|---|---|
| Enterprise Value | $7.27 Billion |
| Dividend Yield | $0.30 (3.37%) |
| Earnings per Share | $0.26 |
| Beta | 0.21 |
| Outstanding Shares | 846,282,012 |
Return
| Return on Equity | 8.95% |
|---|---|
| Return on Assets | 5.94% |
| Return on Invested Capital | 11.45% |
Valuation & Multiples
| P/E Ratio | 23.25 |
|---|---|
| PEG | 10.91 |
| Price to Sales | 2.88 |
| Price to Book Ratio | 2.16 |
| Enterprise Value to Revenue | 2.8 |
| Enterprise Value to EBIT | 14.82 |
| Enterprise Value to Net Income | 22 |
| Total Debt to Enterprise | 0.04 |
| Debt to Equity | 0.07 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
October 26, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Jiuzhitang Co., Ltd.
3,674 employees
CEO: Li Zhen Guo Jiuzhitang Co., Ltd. is a Chinese pharmaceutical company specializing in the development and distribution of traditional Chinese, chemical, biological, and health-related medicinal products. Its product portfolio addresses a wide array o...